Author: Rankin Peter Baldwin Paul
Publisher: American Society of Consultant Pharmacists
ISSN: 0888-5109
Source: The Consultant Pharmacist, Vol.30, Iss.11, 2015-11, pp. : 680-680
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
Wide variation in cancer deaths mapped by congressional district
Cancer, Vol. 122, Iss. 1, 2016-01 ,pp. :
Communicating the New Pharmacovigilance Landscape
Drug Safety, Vol. 35, Iss. 12, 2012-12 ,pp. :
Cholesterol and Coronary Disease—The Altered Landscape
By LaRosa John
Cardiovascular Drugs and Therapy, Vol. 18, Iss. 1, 2004-01 ,pp. :
The duty of disclosure in the post-Therasense landscape
Pharmaceutical Patent Analyst, Vol. 2, Iss. 2, 2013-03 ,pp. :
Navigating the molecular diagnostic patent landscape
By Nicol Dianne
Expert Opinion on Therapeutic Patents, Vol. 18, Iss. 5, 2008-05 ,pp. :